Geomedics Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.21 Cr
as on 16-11-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.06 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.74 Cr
as on 16-11-2024
- Revenue 69.66%
(FY 2023)
- Profit -45.51%
(FY 2023)
- Ebitda -16.79%
(FY 2023)
- Net Worth 52.20%
(FY 2023)
- Total Assets 48.10%
(FY 2023)
About Geomedics Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.21 Cr.
The company currently has active open charges totaling ₹4.06 Cr. The company has closed loans amounting to ₹1.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nailesh Gandhi, Somen Banerjee, and Vaishali Banerjee serve as directors at the Company.
- CIN/LLPIN
U74900PN2015PTC155621
- Company No.
155621
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Geomedics Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nailesh Gandhi  | Director | 30-Jun-2015 | Current |
| Somen Banerjee | Director | 30-Jun-2015 | Current |
| Vaishali Banerjee | Director | 06-Mar-2021 | Current |
Financial Performance of Geomedics Pharma.
Geomedics Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 69.66% increase. The company also saw a substantial fall in profitability, with a 45.51% decrease in profit. The company's net worth Soared by an impressive increase of 52.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Geomedics Pharma?
In 2023, Geomedics Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Geosmatic Cosmeceuticals & Cosmocare Private LimitedActive 16 years 7 monthsNailesh Gandhi, Somen Banerjee and 1 more are mutual person
- Kidoderm Aesthetics Private LimitedActive 2 years 4 months
Somen Banerjee and Vaishali Banerjee are mutual person
- Myderm Aesthetics Private LimitedActive 2 years 4 months
Somen Banerjee and Vaishali Banerjee are mutual person
- Biopharmacieaa Private LimitedActive 5 years 6 months
Somen Banerjee and Vaishali Banerjee are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Oct 2024 | ₹0.19 M | Open |
Others Creation Date: 27 Apr 2023 | ₹2.31 Cr | Open |
Hdfc Bank Limited Creation Date: 31 Jan 2017 | ₹1.74 Cr | Open |
How Many Employees Work at Geomedics Pharma?
Geomedics Pharma has a workforce of 9 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Geomedics Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geomedics Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
